<DOC>
	<DOCNO>NCT01305408</DOCNO>
	<brief_summary>The primary objective study determine whether armodafinil treatment , dosage 150 mg/day , effective placebo treatment adjunctive therapy mood stabilizer treatment adult major depression associate bipolar I disorder .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Armodafinil Treatment ( 150 mg/Day ) Adjunctive Therapy Adults With Major Depression Associated With Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>The patient diagnosis bipolar I disorder accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( Text Revision ) ( DSMIVTR ) criterion currently experience major depressive episode . Documentation patient least 1 previous manic mixed episode . The patient 6 mood episode last year . The patient 's current major depressive episode must start less 2 week 12 month prior screen visit . The current depressive episode must begin patient 's current mood stabilizer regime begin . The patient must take 1 ( 2 ) follow protocolallowed mood stabilizer : lithium , valproic acid , lamotrigine , aripiprazole , olanzapine , quetiapine , risperidone , ziprasidone ( take combination lithium , valproic acid , lamotrigine ) . The following criterion must also meet : 1 . The mood stabilizer ( ) must take minimum 4 week onset major depressive episode still take time screen visit dose blood level consider appropriate maintenance therapy patient 's physician . 2 . The patient must continue take mood stabilizer ( ) screen period ; mood stabilizer may add screen period . 3 . The mood stabilizer ( ) must take minimum least 8 week prior baseline visit . 4 . The dosage mood stabilizer ( ) must stable minimum 4 week prior baseline visit . 5 . The mood stabilizer ( ) must take oral formulation , exception risperidone , either oral longacting injection formulation . 6 . The patient may take 2 protocolallowed mood stabilizer 1 drug lithium , valproic acid , lamotrigine . The patient Axis I disorder apart bipolar I disorder primary focus treatment within 6 month screen visit screen period . The patient psychotic symptom psychosis within 4 week screen visit screen period . The patient current active suicidal ideation , imminent risk selfharm , history significant suicidal ideation suicide attempt time past cause concern present . The patient history eat disorder obsessive compulsive disorder ( OCD ) within 6 month screen visit screen period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Bipolar I Disorder</keyword>
</DOC>